Wednesday, July 8, 2026

pharma · Head and Neck Squamous Cell Carcinoma · Metastatic Head and Neck Squamous Cell Carcinoma · BCAX

Bicara Therapeutics

Bicara Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Boston, USA HQ
2020 Founded
115 Employees
Public company Type
BCAX · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Founded
2020
Employees
115
Programs
6
Drugs
4
Patents
0
Intelligence · Clinical Trials

Bicara Therapeutics clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to Bicara Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Bicara Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Bicara Therapeutics.

  1. BCA101X301 — Phase 3

    Clinical update
  2. Ficerafusp alfa — Phase 3

    Clinical update
  3. Ficerafusp alfa — Phase 2

    Clinical update
  4. Ficerafusp alfa — Phase 2

    Clinical update
  5. Pembrolizumab — Phase 2

    Clinical update
  6. BCA101 — Phase 1

    Clinical update

Trial registry

6 studies